Application Note: Utilization of the ACQUITY PREMIER System and columns for improved oligonucleotide bioanalytical chromatographic performance
19 February 2021

In this application note, Waters highlights the increased chromatographic performance for oligodeoxythymidines (ODTs) and the oligonucleotide antisense therapy, GEM91, using the ACQUITY PREMIER chromatographic system.

Company